Group One Trading
KZR

Group One Trading’s Kezar Life Sciences KZR Stock Holding History

Group One Trading’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,344
Closed -$23.8K – 7978
2023
Q2 		$32.9K Sell
1,344
-9,139
-87% -$238K ﹤0.01% 5605
2023
Q1 		$328K Buy
+10,483
New +$607K ﹤0.01% 3173
2022
Q4 		– Sell
-2,607
Closed -$193K – 7691
2022
Q3 		$224K Sell
2,607
-6,622
-72% -$643K ﹤0.01% 4026
2022
Q2 		$763K Buy
9,229
+8,788
+1,993% +$775K ﹤0.01% 3007
2022
Q1 		$73K Buy
+441
New +$63.3K ﹤0.01% 5793
2021
Q4 		– Sell
-60
Closed -$6.77K – 8542
2021
Q3 		$5K Buy
+60
New +$3.97K ﹤0.01% 7737
2021
Q2 		– Sell
-20
Closed -$1.14K – 8351
2021
Q1 		$1K Sell
20
-445
-96% -$26K ﹤0.01% 7456
2020
Q4 		$24K Hold
465
– – ﹤0.01% 5419
2020
Q3 		$22K Buy
465
+70
+18% +$3.35K ﹤0.01% 5082
2020
Q2 		$20K Buy
+395
New +$19.9K ﹤0.01% 4824

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return

Group One Trading's KZR Position: Q3 2023 in Review

Group One Trading sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 1,344 shares — an estimated $23.8K sold.

Group One Trading first reported a position in KZR in Q2 2020 and held it in 10 quarters. The position peaked at $763K in Q2 2022. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

  • Group One Trading reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 1,344 Kezar Life Sciences shares in Q3 2023, an estimated $23.8K.
  • Group One Trading first reported a position in Kezar Life Sciences in Q2 2020 and held it in 10 quarters.
  • Group One Trading's Kezar Life Sciences position peaked at $763K in Q2 2022.
  • 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.